Krebs Biochemicals & Industries informs about appointment of CFO

14 Sep 2018 Evaluate

In continuation to the outcome of the board meeting regarding appointment of S. Phani Srinath as Chief Financial Officer (CFO) of the company based on the recommendations of the Audit and Nomination and Remuneration Committees, vide the letter dated 10th September 2018, Krebs Biochemicals & Industries has informed about a brief profile of S. Phani Srinath as required under the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

53.50 0.40 (0.75%)
13-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.50
Dr. Reddys Lab 1293.00
Cipla 1314.10
Zydus Lifesciences 906.00
Lupin 2314.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×